Autologous Bone Marrow
Autologous bone marrow refers to a medical procedure where a patient’s own healthy stem cells are collected, stored, and later reinfused into their body. This approach is a crucial component of certain high-dose cancer treatments, aiming to restore the bone marrow’s ability to produce blood cells after intensive therapy.

Key Takeaways
- Autologous bone marrow involves collecting and reinfusing a patient’s own stem cells.
- The autologous bone marrow transplant procedure supports recovery after high-dose cancer treatments.
- Autologous bone marrow uses and benefits include treating specific cancers and autoimmune diseases with reduced immune rejection risks.
- Autologous bone marrow side effects are primarily linked to the intensive conditioning regimen, such as myelosuppression and mucositis.
- This approach enables more aggressive therapy, crucial for eradicating certain cancers.
What is Autologous Bone Marrow?
Autologous bone marrow refers to a patient’s own bone marrow or stem cells collected from their blood, which are then processed and stored for future use. The term “autologous” signifies that the donor and recipient are the same individual, eliminating the risk of immune rejection often associated with donor transplants. This medical technique is foundational in certain advanced therapies, particularly those involving intensive treatments that can damage the body’s ability to produce new blood cells. The primary goal is to restore healthy blood cell production, making it a vital supportive measure in oncology.
Autologous Bone Marrow Transplant Procedure & Uses
An autologous bone marrow transplant is a complex medical procedure designed to replenish a patient’s blood-forming stem cells following high-dose chemotherapy or radiation therapy. These intensive treatments are often necessary to eradicate cancer cells but can severely damage the bone marrow. By reinfusing the patient’s own previously collected stem cells, the body’s ability to generate new blood cells is restored, allowing for recovery from the harsh effects of treatment.
The Transplant Process
The autologous bone marrow transplant procedure typically involves several distinct stages:
- Stem Cell Mobilization and Collection: Medication stimulates the bone marrow to release stem cells into the bloodstream. These are collected via apheresis, where blood is drawn, stem cells separated, and the rest returned.
- Processing and Storage: Collected stem cells are processed and cryopreserved (frozen) to maintain viability.
- Conditioning Regimen: The patient undergoes high-dose chemotherapy, sometimes with radiation, to destroy cancer cells and any remaining unhealthy bone marrow.
- Reinfusion (Transplant): Stored stem cells are thawed and infused intravenously. These cells travel to the bone marrow, engraft, and begin producing new, healthy blood cells. Engraftment typically takes 2-4 weeks.
Therapeutic Applications & Benefits
The autologous bone marrow uses and benefits are significant, primarily in treating various cancers and some autoimmune diseases.
- Cancers: Commonly used for lymphomas (e.g., Hodgkin lymphoma, non-Hodgkin lymphoma), multiple myeloma, and certain solid tumors like germ cell tumors and neuroblastoma.
- Autoimmune Diseases: In select cases, it can be considered for severe autoimmune conditions such as systemic sclerosis or multiple sclerosis, aiming to “reset” the immune system.
Key benefits include:
- No Risk of Graft-versus-Host Disease (GVHD): As cells are from the patient, there’s no immune reaction against the recipient’s tissues.
- Lower Risk of Immune Rejection: The body readily accepts its own cells.
- Availability: The patient’s own cells are always available, eliminating the need for a matched donor.
- Enables High-Dose Therapy: Allows clinicians to administer higher doses of chemotherapy or radiation, often more effective against aggressive cancers.
Potential Side Effects of Autologous Transplants
While offering substantial benefits, it is important to understand the autologous bone marrow side effects. These are primarily associated with the intensive conditioning regimen (high-dose chemotherapy and/or radiation) rather than the transplanted stem cells themselves. The severity and type of side effects vary among individuals.
Common side effects often include:
- Myelosuppression: Leads to low blood cell counts (anemia, neutropenia, thrombocytopenia), increasing infection, bleeding, and fatigue risks. Supportive care, including transfusions and antibiotics, is crucial.
- Nausea and Vomiting: Often severe due to chemotherapy, requiring antiemetic medications.
- Mouth Sores (Mucositis): Painful inflammation and ulceration of the mouth and throat lining.
- Fatigue: Profound tiredness that can persist for weeks or months.
- Hair Loss: A common, temporary side effect of chemotherapy.
- Diarrhea: Frequent gastrointestinal upset.
- Organ Toxicity: High-dose therapy can sometimes affect organs like the liver, kidneys, or heart, though careful monitoring helps mitigate these risks.
Long-term side effects are less common but may include infertility, a small risk of secondary cancers, and chronic fatigue. Patients receive close post-transplant monitoring to manage these potential issues and support recovery.



















